EM Device is a biotech firm focused on revolutionizing abscess treatment through its innovative Quickloop® Abscess Treatment Device. This device streamlines the loop abscess treatment method, allowing doctors to avoid the traditional and more painful incision and drainage technique. The Quickloop® device aims to reduce procedure failure rates, eliminate follow-up visits, improve patient outcomes, shorten provider time, and decrease patient pain.

EM Device has achieved significant milestones, including studies demonstrating reduced treatment failures, fewer return visits, and higher patient satisfaction. The company's impact is evident in its ability to simplify home care and significantly lower pain scores for patients. Notable research by Gottlieb and Schechter-Perkins supports the efficacy of the Quickloop® device, underscoring its transformative potential in the medical field.